Page 109 - MemoriaBBN-Eng
P. 109




www.ciber-bbn.es


• o B, G n, s-m v, A n, n P, m F .. Multi- 
Most relevant lAldeArmendiAáezArtínezrGArAteooeAidorinet Al
functional bioactive glass scaffolds coated with layers of poly(D,L-lactide-co-glycoli- 
scientific de) and poly(n-isopropylacrylamide-co-acrylic acid) microgels loaded with vancomy- 

articles
cin.Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):3760-7.

• Briz n, Antolinos-turPin Cm, Alió J, GArAGorri n, riBelles Jl, Gómez-teJedor JA. Fibro- 

nectin fixation on poly(ethyl acrylate)-based copolymers.J Biomed Mater Res B Appl 
Biomater. 2013 Aug;101(6):991-7.

• B i, o J, A P, B n, i e, á n, A G, F 
rACerAsyArBidezPirozrizPiñAzArlvAreztorrAsAGAstirAtilA
rm, AizPururA Jm. “Plasma-click” based strategy for obtaining antibacterial surfaces 
on implants.Plasma Processes and Polymers. 2013;(10):328-335.




2013 has been a consolidation year for the Biomaterials group in Tecnalia, both in 
Highlights
terms of internal organization and focus of R&D activities. For human resources, 
Dr. Joseba oyarbide has been taken on by Tecnalia, and Dr. Nerea Argarate is now 

the assigned researcher to the Capacity Programme, reinforcing the team to face 

new future research challenges.

On the financial side, the group was granted several relevant Basque government 
projects in the field of 3D printing, strategic research on multifunctional Au nano- 

particles for therapy and in vitro/in vivo diagnostics of cancer.

Several actions has been carried out to reinforce international cooperations (Bra- 
zilian students for trainning in San Sebastian, research project with Serbia, new 

proposal with Paraguay).

In the field of CIBER activities, the team has consolidated the commintment 

through two intramural projects (Teltis and Oligocodes) and try to obtain a third 
new one.

Furthermore, two European patent applications have been extended to PCT.

Finally, the group maintained the status of its authorizationfrom the Ministry of 

Health as Test Laboratory of the 0318 Notified Organism for “Biocompatibility 
UNE-EN-10993”.
















13
20
T 
OR
P
RE
L 
A
NU
N
 A
N /
B
-B
R
BE
CI

109







   107   108   109   110   111